[DOI] [PubMed] [Google Scholar] 32.Bastos D.H.M., de Oliveira D.M., Matsumoto R.L.T., Carvalho P.O., Ribeiro M.L
The term "brain fog" itself is not a standardized clinical endpoint in research studies, making it difficult to draw definitive conclusions
In addition, GLP-1 analogue treatment reduced all-cause mortality by 12%, hospital admission for heart failure by 9%, and a broad composite kidney outcome (development of new-onset macroalbuminuria, decline in estimated glomerular filtration rate [or increase in creatinine], progression to end-stage kidney disease, or death attributable to kidney causes) by 17%, mainly due to a reduction in urinary albumin excretion [27]
Unlike oral medications, Retatrutide is not swallowed but self-injected weekly
Raina R, Chauvin A, Chakraborty R et al (2020) The role of endothelin and endothelin antagonists in chronic kidney disease
This is particularly relevant with retatrutide, where the pace of weight loss is faster and the risk of excessive lean mass loss is proportionally higher, though the glucagon component may offer some muscle-sparing benefit
